AstraZeneca researchers show that automated microscale chromatography can generate process-characterization insights comparable to traditional bench-scale systems, potentially giving bioprocess developers a faster, material-sparing route to robust manufacturing control strategies for complex biologics. The post Microscale Chromatography Moves Toward Manufacturing Readiness appeared first on GEN - Genetic Engineering and Biotechnology News .